These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6335527)

  • 1. [Stabilization and reduction of irritant taste of anti-inflammatory drug pirprofen by beta-cyclodextrin complexation].
    Hibi T; Tatsumi M; Hanabusa M; Higuchi R; Imai T; Otagiri M; Uekama K
    Yakugaku Zasshi; 1984 Sep; 104(9):990-6. PubMed ID: 6335527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stabilization of chlorobutanol with beta-cyclodextrin in suppositories].
    Gyulai M; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):125-8. PubMed ID: 3739724
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of some benzothiadiazine diuretics with beta-cyclodextrin.
    Abdel-Rahman SI; el-Sayed AM
    Acta Pharm Hung; 1990 May; 60(2-3):69-75. PubMed ID: 2386074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of tri-O-methyl-beta-cyclodextrin with drugs. II. Enhanced bioavailability of ketoprofen in rats when administered with tri-O-methyl-beta-cyclodextrin.
    Nakai Y; Yamamoto K; Terada K; Horibe H; Ozawa K
    Chem Pharm Bull (Tokyo); 1983 Oct; 31(10):3745-7. PubMed ID: 6671012
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of dissolution and suppository release characteristics of flurbiprofen by inclusion complexation with heptakis(2,6-di-O-methyl)-beta-cyclodextrin.
    Uekama K; Imai T; Maeda T; Irie T; Hirayama F; Otagiri M
    J Pharm Sci; 1985 Aug; 74(8):841-5. PubMed ID: 4032267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of AD-1590, a non-steroidal antiinflammatory agent, in suppository bases by beta-cyclodextrin complexation.
    Takahashi T; Kagami I; Kitamura K; Nakanishi Y; Imasato Y
    Chem Pharm Bull (Tokyo); 1986 Apr; 34(4):1770-4. PubMed ID: 3487392
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.
    Otagiri M; Uekama K; Imai T; Maeda T; Takadate A; Goya S; Janssen LH
    Acta Pharm Suec; 1984; 21(6):357-66. PubMed ID: 6534072
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of stability and biological effect on cholecalciferol by beta-cyclodextrin complexation.
    Szejtli J; Bolla-Pusztai E; Szabó P; Ferenczy T
    Pharmazie; 1980 Dec; 35(12):779-87. PubMed ID: 6259671
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring by headspace gaschromatography (HSGC) of formation and thermal stability of terpene beta-cyclodextrin complexes.
    Vincieri FF; Mazzi G; Papini P; Gelsomini N
    Farmaco Prat; 1986 Mar; 41(3):98-106. PubMed ID: 3709770
    [No Abstract]   [Full Text] [Related]  

  • 14. Utilization of diethyl-beta-cyclodextrin as a sustained-release carrier for isosorbide dinitrate.
    Hirayama F; Hirashima N; Abe K; Uekama K; Ijitsu T; Ueno M
    J Pharm Sci; 1988 Mar; 77(3):233-6. PubMed ID: 3373427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cycloamylose complexation of adamantane derivatives.
    Gelb RI; Schwartz LM; Laufer DA
    Life Sci; 1983 Jul; 33(1):83-5. PubMed ID: 6865649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of oral bioavailability of spironolactone by beta- and gamma-cyclodextrin complexations.
    Seo H; Tsuruoka M; Hashimoto T; Fujinaga T; Otagiri M; Uekama K
    Chem Pharm Bull (Tokyo); 1983 Jan; 31(1):286-91. PubMed ID: 6850944
    [No Abstract]   [Full Text] [Related]  

  • 17. Thermodynamic study on the effects of beta-cyclodextrin inclusion with anilinonaphthalenesulfonates.
    Catena GC; Bright FV
    Anal Chem; 1989 Apr; 61(8):905-9. PubMed ID: 2719277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-cyclodextrin on the degradation rate of cinnarizine in aqueous solution.
    Tokumura T; Tatsuishi K; Kayano M; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1985 May; 33(5):2079-83. PubMed ID: 4053231
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of a sulfamethoxazole-beta-cyclodextrin complex in suppositories].
    Tóth K; Apostol I
    Acta Pharm Hung; 1986 May; 56(3):133-7. PubMed ID: 3739726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular cavity filling and tabletting with beta-cyclodextrin].
    Hüttenrauch R; Fricke S
    Pharmazie; 1985 May; 40(5):361-2. PubMed ID: 4034643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.